371 related articles for article (PubMed ID: 23071355)
1. Targeting cancer metabolism.
Teicher BA; Linehan WM; Helman LJ
Clin Cancer Res; 2012 Oct; 18(20):5537-45. PubMed ID: 23071355
[TBL] [Abstract][Full Text] [Related]
2. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
3. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.
Schaefer IM; Hornick JL; Bovée JVMG
Lab Invest; 2018 Apr; 98(4):414-426. PubMed ID: 29339836
[TBL] [Abstract][Full Text] [Related]
4. Metabolic alteration in tumorigenesis.
Yang H; Xiong Y; Guan K
Sci China Life Sci; 2013 Dec; 56(12):1067-75. PubMed ID: 24114443
[TBL] [Abstract][Full Text] [Related]
5. Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.
Menendez JA; Alarcón T; Joven J
Cell Cycle; 2014; 13(5):699-709. PubMed ID: 24526120
[TBL] [Abstract][Full Text] [Related]
6. Genetically-defined metabolic reprogramming in cancer.
Mullen AR; DeBerardinis RJ
Trends Endocrinol Metab; 2012 Nov; 23(11):552-9. PubMed ID: 22858391
[TBL] [Abstract][Full Text] [Related]
7. Inborn and acquired metabolic defects in cancer.
Frezza C; Pollard PJ; Gottlieb E
J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
[TBL] [Abstract][Full Text] [Related]
8. The role of mutation of metabolism-related genes in genomic hypermethylation.
Waterfall JJ; Killian JK; Meltzer PS
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):16-23. PubMed ID: 25111818
[TBL] [Abstract][Full Text] [Related]
9. The functional roles of TCA cycle metabolites in cancer.
Eniafe J; Jiang S
Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the TCA cycle: signaling to tumor formation.
Raimundo N; Baysal BE; Shadel GS
Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
[TBL] [Abstract][Full Text] [Related]
11. Metabolic enzymes as oncogenes or tumor suppressors.
Thompson CB
N Engl J Med; 2009 Feb; 360(8):813-5. PubMed ID: 19228626
[No Abstract] [Full Text] [Related]
12. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
13. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
King A; Selak MA; Gottlieb E
Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.
Sciacovelli M; Frezza C
FEBS J; 2017 Oct; 284(19):3132-3144. PubMed ID: 28444969
[TBL] [Abstract][Full Text] [Related]
15. The metabolic alterations of cancer cells.
Sciacovelli M; Gaude E; Hilvo M; Frezza C
Methods Enzymol; 2014; 542():1-23. PubMed ID: 24862258
[TBL] [Abstract][Full Text] [Related]
16. Fumarate hydratase in cancer: A multifaceted tumour suppressor.
Schmidt C; Sciacovelli M; Frezza C
Semin Cell Dev Biol; 2020 Feb; 98():15-25. PubMed ID: 31085323
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy.
Li L; Eid JE; Paz AC; Trent JC
BioDrugs; 2017 Oct; 31(5):379-392. PubMed ID: 28840584
[TBL] [Abstract][Full Text] [Related]
18. Cancer. Puzzling patterns of predisposition.
Pollard PJ; Ratcliffe PJ
Science; 2009 Apr; 324(5924):192-4. PubMed ID: 19359573
[No Abstract] [Full Text] [Related]
19. Aerobic glycolysis: a novel target in kidney cancer.
Shuch B; Linehan WM; Srinivasan R
Expert Rev Anticancer Ther; 2013 Jun; 13(6):711-9. PubMed ID: 23773105
[TBL] [Abstract][Full Text] [Related]
20. Cancer metabolism: key players in metabolic reprogramming.
Soga T
Cancer Sci; 2013 Mar; 104(3):275-81. PubMed ID: 23279446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
